Corporate GovernanceApr 27, 2026, 04:14 PM
ABT Amends By-Laws, Effective April 24, 2026
AI Summary
Abbott Laboratories has amended and restated its By-Laws, effective April 24, 2026. The updated By-Laws detail procedures for annual and special shareholder meetings, including stringent requirements for shareholder nominations of directors and proposals of other business. These amendments aim to ensure proper governance and transparency in shareholder engagement.
Key Highlights
- By-Laws amended and restated, effective April 24, 2026.
- Shareholder notice for annual meeting nominations due 90-120 days prior.
- Shareholder notice for special meeting proposals due 90-120 days prior.
- Special meetings can be called by shareholders with 1/5 (20%) beneficial ownership.
- Special meeting date fixed within 120 days of valid request.
- Meeting notices delivered 10-60 days before meeting (20-60 for certain actions).
- Record date fixed not more than 60 days, not less than 10 days before meeting.
- Quorum requires a majority of outstanding shares entitled to vote.
Price Impact
More from ABT